C

CervoMed
D

CRVO

2.25000
USD
-0.03
(-1.32%)
Post Trading·2.30000USD+0.05000(+2.22%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
1,727
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
34,017,966
أصول ذات صلة

العنوان: CervoMed

القطاع: الرعاية الصحية
الصناعة: Biotechnology
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.